Form 4: Bausch Health Director Amy Wechsler Receives Restricted Share Units

Director Amy Wechsler acquired 35,360 common shares of Bausch Health Companies Inc. through restricted share units (RSUs) granted on May 17, 2024.

Summary

• Amy Wechsler, a director of Bausch Health Companies Inc., acquired 35,360 common shares on May 17, 2024.
• The acquisition was in the form of restricted share units (RSUs) granted as compensation for non-employee directors.
• The RSUs have a grant date value of $250,000 and vest immediately prior to the Issuer's next Annual Meeting of Shareholders.
• The RSUs are settled in common shares of Bausch Health Companies Inc.
• Following the transaction, Wechsler directly owns 205,266 common shares.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction (granting of RSUs to a director), which is generally viewed neutrally to positively as it aligns director interests with shareholders. There are no indications of negative sentiment.

Positives

• The grant of RSUs to non-employee directors aligns their interests with those of shareholders.
• The vesting schedule encourages continued service and commitment to the company.

Future Outlook

The RSUs vest immediately prior to the Issuer's next Annual Meeting of Shareholders, indicating a future event tied to shareholder engagement.

Industry Context

Granting RSUs to directors is a common practice to align their interests with shareholders and incentivize long-term value creation. This is a standard compensation method used across various industries.

Comparison to Industry Standards

• Many companies in the pharmaceutical and healthcare sectors, such as Johnson & Johnson and Pfizer, utilize RSU grants as part of their director compensation packages.
• The value of $250,000 for director RSU grants is within the typical range for companies of Bausch Health's size and market capitalization.
• The immediate vesting prior to the next annual meeting is a fairly standard vesting schedule, aligning with industry norms for director compensation.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it aligns director interests with company performance.
• The director benefits from increased equity ownership in the company.

Next Steps

• The RSUs will vest immediately prior to the Issuer's next Annual Meeting of Shareholders.
• The RSUs will be settled in common shares of Bausch Health Companies Inc.

Key Dates